Victoria Vakiener, Chief Commercial Officer at Epizyme, Inc. (EPZM), sold 599 shares at $11.41 ($7K) on 2021-01-25, disclosed to the SEC on 2021-01-27.
Scheduled sale ($7k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ARWR | SELL | 2024-05-06 | $42K | — | Filing → |
| ARWR | SELL | 2024-01-16 | $317K | — | Filing → |
| ARWR | SELL | 2023-10-02 | $41K | — | Filing → |